Comparison Between Artificial Intelligence and Standard Reading to Investigate Suspected Crohn Disease: the SCAI STUDY

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorFondazione Poliambulanza Istituto Ospedaliero

About this trial

The diagnosis of Crohn's Disease (CD) is based on a combination of clinical, biochemical (serological and fecal), endoscopic, radiological, and histological investigations. In the absence of obstructive symptoms or known stenosis, European guidelines recommend to investigate the small intestine using Video Capsule Endoscopy (VCE) if ileocolonoscopy is not decisive. To reduce the reading time of VCE and increase the number of identified lesions during the examination, various artificial intelligence software/tools have been developed in recent decades. This study aims to be the first prospective multicentric real-life trial to evaluate AI-assisted VCE using SmartScan in identifying typical mucosal abnormalities of the small intestine in patients with suspected CD and its ability to reduce reading time while maintaining the same diagnostic yield and diagnostic accuracy of standard reading. The objective of the study is to evaluate the role of AI-assisted VCE using the OMOM SmartScan in detecting typical small bowel inflammatory lesions (i.e. erosions and ulcers) in patients with suspected CD, and comparing AI with standard reading.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age >= 18 and <= 75 years

Clinical suspicion of Crohn's Disease (CD) with/without occlusive symptoms

Ileocolonoscopy: negative examination, aspecific inflammatory findings

Signed informed consent form

Disqualifiers

Known diagnosis of CD

Endoscopic diagnosis of active diverticular disease, colorectal cancer, ulcerative colitis, or infectious colitis, microscopic colitis

Positive stool tests for pathogenic bacteria, Yersinia enterocolitica, parasites, C. difficile infection, fecal antigen for Giardia lamblia within 6 months before VCE

Known intestinal obstruction or unconfirmed small bowel patency

Trial population

Eligible patients for the study are those with clinical symptoms and laboratory results suggestive of CD who have previously undergone an ileocolonoscopy which excluded other organic pathology and/or resulted inconclusive for CD (aspecific terminal ileitis).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Small bowel Video Capsule Endoscopy (VCE) using an Capsule System equipped with a Deep Neural Network based system called SmartScan (SC),

    Device

    Small bowel Video Capsule Endoscopy (VCE) will be performed using the an Capsule System equipped with a Deep Neural Network based system called SmartScan (SC), which is able to automatically select suspected lesions thus creating a very short video constituted only by selected images.

Treatment groups

180 Participants
are divided into 1 treatment group
Group A: Suspected Crohn's Disease1 intervention

Trial outcomes

Primary outcomes

1

Diagnostic yield (DY)

Non-inferiority of AI-assisted reading (AIR) compared to standard reading (SR) in detecting (diagnostic yield - DY) typical lesions of suspected CD (erosions and/or ulcers and/or stenosis).

Time frame
through study completion, an average of 1 year

Secondary outcomes

1

VCE reading time

Small bowel reading time of video capsule endoscopy in two setting: Artificial Intelligence Reading and in Standard Reading

Time frame
through study completion, an average of 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.